Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioXcel Therapeutics (BTAI) Depreciation and Depletion (2022 - 2025)

BioXcel Therapeutics has reported Depreciation and Depletion over the past 4 years, most recently at $74000.0 for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $74000.0 for Q4 2025, down 3.9% from a year ago — trailing twelve months through Dec 2025 was $300000.0 (down 2.91% YoY), and the annual figure for FY2025 was $300000.0, down 2.91%.
  • Depreciation and Depletion for Q4 2025 was $74000.0 at BioXcel Therapeutics, down from $75000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for BTAI hit a ceiling of $85000.0 in Q3 2022 and a floor of $74000.0 in Q4 2025.
  • Median Depreciation and Depletion over the past 4 years was $77500.0 (2022), compared with a mean of $78375.0.
  • Peak annual rise in Depreciation and Depletion hit 3.9% in 2023, while the deepest fall reached 7.06% in 2023.
  • BioXcel Therapeutics' Depreciation and Depletion stood at $81000.0 in 2022, then dropped by 3.7% to $78000.0 in 2023, then decreased by 1.28% to $77000.0 in 2024, then dropped by 3.9% to $74000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $74000.0 (Q4 2025), $75000.0 (Q3 2025), and $75000.0 (Q2 2025) per Business Quant data.